[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Europe Active Pharmaceutical Ingredients Market Report 2021

September 2016 | 108 pages | ID: E8306A65F6DEN
QYResearch

US$ 4,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Active Pharmaceutical Ingredients

Revenue, means the sales value of Active Pharmaceutical Ingredients

This report studies sales (consumption) of Active Pharmaceutical Ingredients in Europe market, especially in Germany, UK, France, Italy, Spain and Russia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
  • Teva Active Pharmaceutical Industries Limited
  • DSM
  • Novartis
  • Roche
  • Johnson?&?Johnson
  • Dr. Reddy’s
  • Pfizer
  • Bayer
  • BASF
  • Cambrex
  • Sun Pharmaceutical Industries
  • Lonza group
  • Boehringer Ingelheim GmbH
  • Aurobindo pharma
  • Lupin
  • Biocon
  • Cipla
  • Hisun Pharmacy
  • Huahai Pharmaceutical
  • North China Pharmaceutical Group
  • Shandong Lukang Pharmaceutical Co., Ltd
  • Haerbin Pharmaceutical Group
  • Shandong Xinhua Pharmaceutical Co.,Ltd
  • Jiangsu Hengrui Medicine
  • Tian Yao
  • North East Pharmaceutical
  • Zhejiang Medicine
Market Segment by Regions, this report splits Europe into several key Regions, with sales (consumption), revenue, market share and growth rate of Active Pharmaceutical Ingredients in these regions, from 2011 to 2021 (forecast), like
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by applications, this report focuses on sales, market share and growth rate of Active Pharmaceutical Ingredients in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
1 ACTIVE PHARMACEUTICAL INGREDIENTS OVERVIEW

1.1 Product Overview and Scope of Active Pharmaceutical Ingredients
1.2 Classification of Active Pharmaceutical Ingredients
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Applications of Active Pharmaceutical Ingredients
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Active Pharmaceutical Ingredients Market by Regions
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Italy Status and Prospect (2011-2021)
  1.4.5 Spain Status and Prospect (2011-2021)
  1.4.6 Russia Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Active Pharmaceutical Ingredients (2011-2021)
  1.5.1 Europe Active Pharmaceutical Ingredients Sales, Revenue and Price (2011-2021)
  1.5.2 Europe Active Pharmaceutical Ingredients Sales and Growth Rate (2011-2021)
  1.5.3 Europe Active Pharmaceutical Ingredients Revenue and Growth Rate (2011-2021)

2 EUROPE ACTIVE PHARMACEUTICAL INGREDIENTS BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Active Pharmaceutical Ingredients Market Competition by Manufacturers
  2.1.1 Europe Active Pharmaceutical Ingredients Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Active Pharmaceutical Ingredients Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Active Pharmaceutical Ingredients (Volume and Value) by Type
  2.2.1 Europe Active Pharmaceutical Ingredients Sales and Market Share by Type (2011-2021)
  2.2.2 Europe Active Pharmaceutical Ingredients Revenue and Market Share by Type (2011-2021)
2.3 Europe Active Pharmaceutical Ingredients (Volume and Value) by Regions
  2.3.1 Europe Active Pharmaceutical Ingredients Sales and Market Share by Regions (2011-2021)
  2.3.2 Europe Active Pharmaceutical Ingredients Revenue and Market Share by Regions (2011-2021)
2.4 Europe Active Pharmaceutical Ingredients (Volume) by Application

3 GERMANY ACTIVE PHARMACEUTICAL INGREDIENTS (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Active Pharmaceutical Ingredients Sales and Value (2011-2021)
  3.1.1 Germany Active Pharmaceutical Ingredients Sales and Growth Rate (2011-2021)
  3.1.2 Germany Active Pharmaceutical Ingredients Revenue and Growth Rate (2011-2021)
  3.1.3 Germany Active Pharmaceutical Ingredients Sales Price Trend (2011-2021)
3.2 Germany Active Pharmaceutical Ingredients Sales and Market Share by Manufacturers
3.3 Germany Active Pharmaceutical Ingredients Sales and Market Share by Type
3.4 Germany Active Pharmaceutical Ingredients Sales and Market Share by Applications

4 UK ACTIVE PHARMACEUTICAL INGREDIENTS (VOLUME, VALUE AND SALES PRICE)

4.1 UK Active Pharmaceutical Ingredients Sales and Value (2011-2021)
  4.1.1 UK Active Pharmaceutical Ingredients Sales and Growth Rate (2011-2021)
  4.1.2 UK Active Pharmaceutical Ingredients Revenue and Growth Rate (2011-2021)
  4.1.3 UK Active Pharmaceutical Ingredients Sales Price Trend (2011-2021)
4.2 UK Active Pharmaceutical Ingredients Sales and Market Share by Manufacturers
4.3 UK Active Pharmaceutical Ingredients Sales and Market Share by Type
4.4 UK Active Pharmaceutical Ingredients Sales and Market Share by Applications

5 FRANCE ACTIVE PHARMACEUTICAL INGREDIENTS (VOLUME, VALUE AND SALES PRICE)

5.1 France Active Pharmaceutical Ingredients Sales and Value (2011-2021)
  5.1.1 France Active Pharmaceutical Ingredients Sales and Growth Rate (2011-2021)
  5.1.2 France Active Pharmaceutical Ingredients Revenue and Growth Rate (2011-2021)
  5.1.3 France Active Pharmaceutical Ingredients Sales Price Trend (2011-2021)
5.2 France Active Pharmaceutical Ingredients Sales and Market Share by Manufacturers
5.3 France Active Pharmaceutical Ingredients Sales and Market Share by Type
5.4 France Active Pharmaceutical Ingredients Sales and Market Share by Applications

6 ITALY ACTIVE PHARMACEUTICAL INGREDIENTS (VOLUME, VALUE AND SALES PRICE)

6.1 Italy Active Pharmaceutical Ingredients Sales and Value (2011-2021)
  6.1.1 Italy Active Pharmaceutical Ingredients Sales and Growth Rate (2011-2021)
  6.1.2 Italy Active Pharmaceutical Ingredients Revenue and Growth Rate (2011-2021)
  6.1.3 Italy Active Pharmaceutical Ingredients Sales Price Trend (2011-2021)
6.2 Italy Active Pharmaceutical Ingredients Sales and Market Share by Manufacturers
6.3 Italy Active Pharmaceutical Ingredients Sales and Market Share by Type
6.4 Italy Active Pharmaceutical Ingredients Sales and Market Share by Applications

7 RUSSIA ACTIVE PHARMACEUTICAL INGREDIENTS (VOLUME, VALUE AND SALES PRICE)

7.1 Russia Active Pharmaceutical Ingredients Sales and Value (2011-2021)
  7.1.1 Russia Active Pharmaceutical Ingredients Sales and Growth Rate (2011-2021)
  7.1.2 Russia Active Pharmaceutical Ingredients Revenue and Growth Rate (2011-2021)
  7.1.3 Russia Active Pharmaceutical Ingredients Sales Price Trend (2011-2021)
7.2 Russia Active Pharmaceutical Ingredients Sales and Market Share by Manufacturers
7.3 Russia Active Pharmaceutical Ingredients Sales and Market Share by Type
7.4 Russia Active Pharmaceutical Ingredients Sales and Market Share by Applications

8 SPAIN ACTIVE PHARMACEUTICAL INGREDIENTS (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Active Pharmaceutical Ingredients Sales and Value (2011-2021)
  8.1.1 Spain Active Pharmaceutical Ingredients Sales and Growth Rate (2011-2021)
  8.1.2 Spain Active Pharmaceutical Ingredients Revenue and Growth Rate (2011-2021)
  8.1.3 Spain Active Pharmaceutical Ingredients Sales Price Trend (2011-2021)
8.2 Spain Active Pharmaceutical Ingredients Sales and Market Share by Manufacturers
8.3 Spain Active Pharmaceutical Ingredients Sales and Market Share by Type
8.4 Spain Active Pharmaceutical Ingredients Sales and Market Share by Applications

9 EUROPE ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURERS ANALYSIS

9.1 Teva Active Pharmaceutical Industries Limited
  9.1.1 Company Basic Information,Manufacturing Base and Competitors
  9.1.2 Active Pharmaceutical Ingredients Product Type and Technology
    9.1.2.1 Type I
    9.1.2.2 Type II
  9.1.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Teva Active Pharmaceutical Industries Limited (2015 and 2016)
9.2 DSM
  9.2.1 Company Basic Information,Manufacturing Base and Competitors
  9.2.2 Active Pharmaceutical Ingredients Product Type and Technology
    9.2.2.1 Type I
    9.2.2.2 Type II
  9.2.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of DSM (2015 and 2016)
9.3 Novartis
  9.3.1 Company Basic Information,Manufacturing Base and Competitors
  9.3.2 Active Pharmaceutical Ingredients Product Type and Technology
    9.3.2.1 Type I
    9.3.2.2 Type II
  9.3.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Novartis (2015 and 2016)
9.4 Roche
  9.4.1 Company Basic Information,Manufacturing Base and Competitors
  9.4.2 Active Pharmaceutical Ingredients Product Type and Technology
    9.4.2.1 Type I
    9.4.2.2 Type II
  9.4.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Roche (2015 and 2016)
9.5 Johnson?&?Johnson
  9.5.1 Company Basic Information,Manufacturing Base and Competitors
  9.5.2 Active Pharmaceutical Ingredients Product Type and Technology
    9.5.2.1 Type I
    9.5.2.2 Type II
  9.5.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Johnson?&?Johnson (2015 and 2016)
9.6 Dr. Reddy’s
  9.6.1 Company Basic Information,Manufacturing Base and Competitors
  9.6.2 Active Pharmaceutical Ingredients Product Type and Technology
    9.6.2.1 Type I
    9.6.2.2 Type II
  9.6.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Dr. Reddy’s (2015 and 2016)
9.7 Pfizer
  9.7.1 Company Basic Information,Manufacturing Base and Competitors
  9.7.2 Active Pharmaceutical Ingredients Product Type and Technology
    9.7.2.1 Type I
    9.7.2.2 Type II
  9.7.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Pfizer (2015 and 2016)
9.8 Bayer
  9.8.1 Company Basic Information,Manufacturing Base and Competitors
  9.8.2 Active Pharmaceutical Ingredients Product Type and Technology
    9.8.2.1 Type I
    9.8.2.2 Type II
  9.8.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Bayer (2015 and 2016)
9.9 BASF
  9.9.1 Company Basic Information,Manufacturing Base and Competitors
  9.9.2 Active Pharmaceutical Ingredients Product Type and Technology
    9.9.2.1 Type I
    9.9.2.2 Type II
  9.9.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of BASF (2015 and 2016)
9.10 Cambrex
  9.10.1 Company Basic Information,Manufacturing Base and Competitors
  9.10.2 Active Pharmaceutical Ingredients Product Type and Technology
    9.10.2.1 Type I
    9.10.2.2 Type II
  9.10.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Cambrex (2015 and 2016)
9.11 Sun Pharmaceutical Industries
  9.11.1 Company Basic Information,Manufacturing Base and Competitors
  9.11.2 Active Pharmaceutical Ingredients Product Type and Technology
    9.11.2.1 Type I
    9.11.2.2 Type II
  9.11.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Sun Pharmaceutical Industries (2015 and 2016)
9.12 Lonza group
  9.12.1 Company Basic Information,Manufacturing Base and Competitors
  9.12.2 Active Pharmaceutical Ingredients Product Type and Technology
    9.12.2.1 Type I
    9.12.2.2 Type II
  9.12.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Lonza group (2015 and 2016)
9.13 Boehringer Ingelheim GmbH
  9.13.1 Company Basic Information,Manufacturing Base and Competitors
  9.13.2 Active Pharmaceutical Ingredients Product Type and Technology
    9.13.2.1 Type I
    9.13.2.2 Type II
  9.13.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Boehringer Ingelheim GmbH (2015 and 2016)
9.14 Aurobindo pharma
  9.14.1 Company Basic Information,Manufacturing Base and Competitors
  9.14.2 Active Pharmaceutical Ingredients Product Type and Technology
    9.14.2.1 Type I
    9.14.2.2 Type II
  9.14.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Aurobindo pharma (2015 and 2016)
9.15 Lupin
  9.15.1 Company Basic Information,Manufacturing Base and Competitors
  9.15.2 Active Pharmaceutical Ingredients Product Type and Technology
    9.15.2.1 Type I
    9.15.2.2 Type II
  9.15.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Lupin (2015 and 2016)
9.16 Biocon
  9.16.1 Company Basic Information,Manufacturing Base and Competitors
  9.16.2 Active Pharmaceutical Ingredients Product Type and Technology
    9.16.2.1 Type I
    9.16.2.2 Type II
  9.16.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Biocon (2015 and 2016)
9.17 Cipla
  9.17.1 Company Basic Information,Manufacturing Base and Competitors
  9.17.2 Active Pharmaceutical Ingredients Product Type and Technology
    9.17.2.1 Type I
    9.17.2.2 Type II
  9.17.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Cipla (2015 and 2016)
9.18 Hisun Pharmacy
  9.18.1 Company Basic Information,Manufacturing Base and Competitors
  9.18.2 Active Pharmaceutical Ingredients Product Type and Technology
    9.18.2.1 Type I
    9.18.2.2 Type II
  9.18.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Hisun Pharmacy (2015 and 2016)
9.19 Huahai Pharmaceutical
  9.19.1 Company Basic Information,Manufacturing Base and Competitors
  9.19.2 Active Pharmaceutical Ingredients Product Type and Technology
    9.19.2.1 Type I
    9.19.2.2 Type II
  9.19.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Huahai Pharmaceutical (2015 and 2016)
9.20 North China Pharmaceutical Group
  9.20.1 Company Basic Information,Manufacturing Base and Competitors
  9.20.2 Active Pharmaceutical Ingredients Product Type and Technology
    9.20.2.1 Type I
    9.20.2.2 Type II
  9.20.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of North China Pharmaceutical Group (2015 and 2016)
9.21 Shandong Lukang Pharmaceutical Co., Ltd
  9.21.1 Company Basic Information,Manufacturing Base and Competitors
  9.21.2 Active Pharmaceutical Ingredients Product Type and Technology
    9.21.2.1 Type I
    9.21.2.2 Type II
  9.21.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Shandong Lukang Pharmaceutical Co., Ltd (2015 and 2016)
9.22 Haerbin Pharmaceutical Group
  9.22.1 Company Basic Information,Manufacturing Base and Competitors
  9.22.2 Active Pharmaceutical Ingredients Product Type and Technology
    9.22.2.1 Type I
    9.22.2.2 Type II
  9.22.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Haerbin Pharmaceutical Group (2015 and 2016)
9.23 Shandong Xinhua Pharmaceutical Co.,Ltd
  9.23.1 Company Basic Information,Manufacturing Base and Competitors
  9.23.2 Active Pharmaceutical Ingredients Product Type and Technology
    9.23.2.1 Type I
    9.23.2.2 Type II
  9.23.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Shandong Xinhua Pharmaceutical Co.,Ltd (2015 and 2016)
9.24 Jiangsu Hengrui Medicine
  9.24.1 Company Basic Information,Manufacturing Base and Competitors
  9.24.2 Active Pharmaceutical Ingredients Product Type and Technology
    9.24.2.1 Type I
    9.24.2.2 Type II
  9.24.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Jiangsu Hengrui Medicine (2015 and 2016)
9.25 Tian Yao
  9.25.1 Company Basic Information,Manufacturing Base and Competitors
  9.25.2 Active Pharmaceutical Ingredients Product Type and Technology
    9.25.2.1 Type I
    9.25.2.2 Type II
  9.25.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Tian Yao (2015 and 2016)
9.26 North East Pharmaceutical
  9.26.1 Company Basic Information,Manufacturing Base and Competitors
  9.26.2 Active Pharmaceutical Ingredients Product Type and Technology
    9.26.2.1 Type I
    9.26.2.2 Type II
  9.26.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of North East Pharmaceutical (2015 and 2016)
9.27 Zhejiang Medicine
  9.27.1 Company Basic Information,Manufacturing Base and Competitors
  9.27.2 Active Pharmaceutical Ingredients Product Type and Technology
    9.27.2.1 Type I
    9.27.2.2 Type II
  9.27.3 Active Pharmaceutical Ingredients Sales, Revenue, Price of Zhejiang Medicine (2015 and 2016)

10 ACTIVE PHARMACEUTICAL INGREDIENTS TECHNOLOGY AND DEVELOPMENT TREND

10.1 Active Pharmaceutical Ingredients Technology Analysis
10.2 Active Pharmaceutical Ingredients Technology Development Trend

11 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES AND FIGURES

Figure Picture of Active Pharmaceutical Ingredients
Table Classification of Active Pharmaceutical Ingredients
Figure Europe Sales Market Share of Active Pharmaceutical Ingredients by Types in 2015
Table Applications of Active Pharmaceutical Ingredients
Figure Europe Sales Market Share of Active Pharmaceutical Ingredients by Applications in 2015
Figure Germany Active Pharmaceutical Ingredients Revenue and Growth Rate (2011-2021)
Figure France Active Pharmaceutical Ingredients Revenue and Growth Rate (2011-2021)
Figure UK Active Pharmaceutical Ingredients Revenue and Growth Rate (2011-2021)
Figure Italy Active Pharmaceutical Ingredients Revenue and Growth Rate (2011-2021)
Figure Spain Active Pharmaceutical Ingredients Revenue and Growth Rate (2011-2021)
Figure Russia Active Pharmaceutical Ingredients Revenue and Growth Rate (2011-2021)
Table Europe Active Pharmaceutical Ingredients Sales, Revenue and Price (2011-2021)
Figure Europe Active Pharmaceutical Ingredients Sales and Growth Rate (2011-2021)
Figure Europe Active Pharmaceutical Ingredients Revenue and Growth Rate (2011-2021)
Table Europe Active Pharmaceutical Ingredients Sales of Key Manufacturers (2015 and 2016)
Table Europe Active Pharmaceutical Ingredients Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Active Pharmaceutical Ingredients Sales Share by Manufacturers
Figure 2016 Active Pharmaceutical Ingredients Sales Share by Manufacturers
Table Europe Active Pharmaceutical Ingredients Revenue by Manufacturers (2015 and 2016)
Table Europe Active Pharmaceutical Ingredients Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Active Pharmaceutical Ingredients Revenue Share by Manufacturers
Table 2016 Europe Active Pharmaceutical Ingredients Revenue Share by Manufacturers
Table Europe Active Pharmaceutical Ingredients Sales and Market Share by Type (2011-2021)
Table Europe Active Pharmaceutical Ingredients Sales Share by Type (2011-2021)
Figure Sales Market Share of Active Pharmaceutical Ingredients by Type (2011-2021)
Figure Europe Active Pharmaceutical Ingredients Sales Growth Rate by Type (2011-2021)
Table Europe Active Pharmaceutical Ingredients Revenue and Market Share by Type (2011-2021)
Table Europe Active Pharmaceutical Ingredients Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Active Pharmaceutical Ingredients by Type (2011-2021)
Figure Europe Active Pharmaceutical Ingredients Revenue Growth Rate by Type (2011-2021)
Table Europe Active Pharmaceutical Ingredients Sales and Market Share by Regions (2011-2021)
Table Europe Active Pharmaceutical Ingredients Sales Share by Regions (2011-2021)
Figure Sales Market Share of Active Pharmaceutical Ingredients by Regions (2011-2021)
Figure Europe Active Pharmaceutical Ingredients Sales Growth Rate by Regions (2011-2021)
Table Europe Active Pharmaceutical Ingredients Revenue and Market Share by Regions (2011-2021)
Table Europe Active Pharmaceutical Ingredients Revenue Share by Regions (2011-2021)
Figure Revenue Market Share of Active Pharmaceutical Ingredients by Regions (2011-2021)
Figure Europe Active Pharmaceutical Ingredients Revenue Growth Rate by Regions (2011-2021)
Table Europe Active Pharmaceutical Ingredients Sales and Market Share by Application (2011-2021)
Table Europe Active Pharmaceutical Ingredients Sales Share by Application (2011-2021)
Figure Sales Market Share of Active Pharmaceutical Ingredients by Application (2011-2021)
Figure Europe Active Pharmaceutical Ingredients Sales Growth Rate by Application (2011-2021)
Figure Germany Active Pharmaceutical Ingredients Sales and Growth Rate (2011-2021)
Figure Germany Active Pharmaceutical Ingredients Revenue and Growth Rate (2011-2021)
Figure Germany Active Pharmaceutical Ingredients Sales Price Trend (2011-2021)
Table Germany Active Pharmaceutical Ingredients Sales by Manufacturers (2015 and 2016)
Table Germany Active Pharmaceutical Ingredients Market Share by Manufacturers (2015 and 2016)
Table Germany Active Pharmaceutical Ingredients Sales by Type (2015 and 2016)
Table Germany Active Pharmaceutical Ingredients Market Share by Type (2015 and 2016)
Table Germany Active Pharmaceutical Ingredients Sales by Applications (2015 and 2016)
Table Germany Active Pharmaceutical Ingredients Market Share by Applications (2015 and 2016)
Figure UK Active Pharmaceutical Ingredients Sales and Growth Rate (2011-2021)
Figure UK Active Pharmaceutical Ingredients Revenue and Growth Rate (2011-2021)
Figure UK Active Pharmaceutical Ingredients Sales Price Trend (2011-2021)
Table UK Active Pharmaceutical Ingredients Sales by Manufacturers (2015 and 2016)
Table UK Active Pharmaceutical Ingredients Market Share by Manufacturers (2015 and 2016)
Table UK Active Pharmaceutical Ingredients Sales by Type (2015 and 2016)
Table UK Active Pharmaceutical Ingredients Market Share by Type (2015 and 2016)
Table UK Active Pharmaceutical Ingredients Sales by Applications (2015 and 2016)
Table UK Active Pharmaceutical Ingredients Market Share by Applications (2015 and 2016)
Figure France Active Pharmaceutical Ingredients Sales and Growth Rate (2011-2021)
Figure France Active Pharmaceutical Ingredients Revenue and Growth Rate (2011-2021)
Figure France Active Pharmaceutical Ingredients Sales Price Trend (2011-2021)
Table France Active Pharmaceutical Ingredients Sales by Manufacturers (2015 and 2016)
Table France Active Pharmaceutical Ingredients Market Share by Manufacturers (2015 and 2016)
Table France Active Pharmaceutical Ingredients Sales by Type (2015 and 2016)
Table France Active Pharmaceutical Ingredients Market Share by Type (2015 and 2016)
Table France Active Pharmaceutical Ingredients Sales by Applications (2015 and 2016)
Table France Active Pharmaceutical Ingredients Market Share by Applications (2015 and 2016)
Figure Italy Active Pharmaceutical Ingredients Sales and Growth Rate (2011-2021)
Figure Italy Active Pharmaceutical Ingredients Revenue and Growth Rate (2011-2021)
Figure Italy Active Pharmaceutical Ingredients Sales Price Trend (2011-2021)
Table Italy Active Pharmaceutical Ingredients Sales by Manufacturers (2015 and 2016)
Table Italy Active Pharmaceutical Ingredients Market Share by Manufacturers (2015 and 2016)
Table Italy Active Pharmaceutical Ingredients Sales by Type (2015 and 2016)
Table Italy Active Pharmaceutical Ingredients Market Share by Type (2015 and 2016)
Table Italy Active Pharmaceutical Ingredients Sales by Applications (2015 and 2016)
Table Italy Active Pharmaceutical Ingredients Market Share by Applications (2015 and 2016)
Figure Russia Active Pharmaceutical Ingredients Sales and Growth Rate (2011-2021)
Figure Russia Active Pharmaceutical Ingredients Revenue and Growth Rate (2011-2021)
Figure Russia Active Pharmaceutical Ingredients Sales Price Trend (2011-2021)
Table Russia Active Pharmaceutical Ingredients Sales by Manufacturers (2015 and 2016)
Table Russia Active Pharmaceutical Ingredients Market Share by Manufacturers (2015 and 2016)
Table Russia Active Pharmaceutical Ingredients Sales by Type (2015 and 2016)
Table Russia Active Pharmaceutical Ingredients Market Share by Type (2015 and 2016)
Table Russia Active Pharmaceutical Ingredients Sales by Applications (2015 and 2016)
Table Russia Active Pharmaceutical Ingredients Market Share by Applications (2015 and 2016)
Figure Spain Active Pharmaceutical Ingredients Sales and Growth Rate (2011-2021)
Figure Spain Active Pharmaceutical Ingredients Revenue and Growth Rate (2011-2021)
Figure Spain Active Pharmaceutical Ingredients Sales Price Trend (2011-2021)
Table Spain Active Pharmaceutical Ingredients Sales by Manufacturers (2015 and 2016)
Table Spain Active Pharmaceutical Ingredients Market Share by Manufacturers (2015 and 2016)
Table Spain Active Pharmaceutical Ingredients Sales by Type (2015 and 2016)
Table Spain Active Pharmaceutical Ingredients Market Share by Type (2015 and 2016)
Table Spain Active Pharmaceutical Ingredients Sales by Applications (2015 and 2016)
Table Spain Active Pharmaceutical Ingredients Market Share by Applications (2015 and 2016)
Table Teva Active Pharmaceutical Industries Limited Basic Information List
Table Active Pharmaceutical Ingredients Sales, Revenue, Price of Teva Active Pharmaceutical Industries Limited (2015 and 2016)
Table DSM Basic Information List
Table Active Pharmaceutical Ingredients Sales, Revenue, Price of DSM (2015 and 2016)
Table Novartis Basic Information List
Table Active Pharmaceutical Ingredients Sales, Revenue, Price of Novartis (2015 and 2016)
Table Roche Basic Information List
Table Active Pharmaceutical Ingredients Sales, Revenue, Price of Roche (2015 and 2016)
Table Johnson?&?Johnson Basic Information List
Table Active Pharmaceutical Ingredients Sales, Revenue, Price of Johnson?&?Johnson (2015 and 2016)
Table Dr. Reddy’s Basic Information List
Table Active Pharmaceutical Ingredients Sales, Revenue, Price of Dr. Reddy’s (2015 and 2016)
Table Pfizer Basic Information List
Table Active Pharmaceutical Ingredients Sales, Revenue, Price of Pfizer (2015 and 2016)
Table Bayer Basic Information List
Table Active Pharmaceutical Ingredients Sales, Revenue, Price of Bayer (2015 and 2016)
Table BASF Basic Information List
Table Active Pharmaceutical Ingredients Sales, Revenue, Price of BASF (2015 and 2016)
Table Cambrex Basic Information List
Table Active Pharmaceutical Ingredients Sales, Revenue, Price of Cambrex (2015 and 2016)


More Publications